Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic CellsSemih U. Tareen, Scott H. Robbins, James M. Allen et al.|Molecular Therapy|2013Cited by 32
CD8-Targeted, Integrating Viral Vectors Transduce Resting T Cells and Enable Extracorporeal Delivery (ECD) for Rapid CAR T Cell TherapiesJesse Green, Terry J. Fry, Adam Johnson et al.|Blood|2022Cited by 5
Abstract 702: DCVex(TM): A novel integration-deficient lentivector technology that incorporates genetic and post-translational elements to target dendritic cellsSemih U. Tareen, Peter Berglund, Christopher J. Nicolai et al.|Cancer Research|2014Cited by 0
PS2-083 Immunization with a novel dc-targeting lentiviral vector induces polyfunctional cd8 t cell responses and therapeutic anti-tumor immunityScott H. Robbins, Thomas W. Dubensky, B. Kelley Clarke et al.|Cytokine|2011Cited by 0
Relieving Restriction in Resting CD8+ T Cells Increases Gene Transfer and Improves Tumor Killing after Transduction with CD8-Targeted CD19CAR FusosomeMariliis Ott, Terry J. Fry, Hadega Aamer et al.|Blood|2024Cited by 0